UNSPSC 51451801: Albendazole

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4216019LN. European Medicines Agency schedules Albendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05295MIG. Albendazole generally arises in the molecular formula C12H15N3O2S.

UNSPSC 51451801 Albendazole is a Commodity code for a specific antiparasitic pharmaceutical, but the most recent state and local opportunities tagged under it do not procure albendazole itself. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over 12 months with renewal options for years 2 and 3. Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. State and local health agencies and counties use the code to procure medications and related pharmaceutical supplies through cooperative purchasing vehicles and traditional competitive bidding, though the actual products being ordered under this code do not match its nominal scope.

Activity appears limited to health departments and county community health systems in Florida and Illinois. The Illinois award was completed through an Invitation for Bid process under the MMCAP Infuse consortium piggyback vehicle, with no set-aside requirements or domestic product preferences applied. The Seminole County IFB carried a July 26, 2023, response deadline and required quarterly deliveries to a specified community health building, with E-Verify compliance and standard insurance coverage (workers' compensation, commercial general liability, and professional liability) as conditions. Neither opportunity explicitly required or identified Business Enterprise Program or Veterans Business Program participation. The code shows minimal recent relevant activity aligned to its pharmaceutical scope, and bidders should verify current active solicitations before committing resources to pursue opportunities under this classification.